Iterum Therapeutics PLC (ITRM)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: ITRM Exchange: NMS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-12-27 2023-12-22 B Purchase

Dunne Michael W.

Non-Executive Director
25,000 +28.2%
1.40
35,000 USD 		25,000 +28.2% 1.40 35,000 USD
2023-12-19 2023-12-18 B Purchase

Dunne Michael W.

Non-Executive Director
10,000 +12.7%
1.84
18,442 USD 		10,000 +12.7% 1.84 18,442 USD
2023-11-27 2023-11-22 B Purchase

Dunne Michael W.

Non-Executive Director
20,000 +34.0%
2.03
40,690 USD 		20,000 +34.0% 2.03 40,690 USD
2023-11-20 2023-11-20 B Purchase

Fishman Corey N.

Chief Executive Officer

Executive Director
10,000 +22.5%
1.59
15,863 USD 		10,000 +22.5% 1.59 15,863 USD
2022-12-05 2022-12-02 S Sale

Puttagunta Sailaja

Chief Medical Officer

Officer
3,365 -40.4%
1.32
4,442 USD 		3,365 -40.4% 1.32 4,442 USD
2022-09-20 2022-09-20 S Sale

Ahrens Brenton Karl

Non-Executive Director
7,246 -100.0%
1.78
12,910 USD 		7,246 -100.0% 1.78 12,910 USD
2022-09-20 2022-09-19 S Sale

Ahrens Brenton Karl

Non-Executive Director
15,000 -67.4%
1.77
26,478 USD 		15,000 -67.4% 1.77 26,478 USD
2022-09-20 2022-09-16 S Sale

Ahrens Brenton Karl

Non-Executive Director
15,000 -40.3%
1.90
28,542 USD 		15,000 -40.3% 1.90 28,542 USD
2022-09-15 2022-09-15 S Sale

Ahrens Brenton Karl

Non-Executive Director
15,000 -28.7%
2.02
30,272 USD 		15,000 -28.7% 2.02 30,272 USD
2022-09-15 2022-09-14 S Sale

Ahrens Brenton Karl

Non-Executive Director
15,000 -22.3%
2.10
31,457 USD 		15,000 -22.3% 2.10 31,457 USD
2022-09-15 2022-09-13 S Sale

Ahrens Brenton Karl

Non-Executive Director
15,000 -18.2%
2.14
32,118 USD 		15,000 -18.2% 2.14 32,118 USD
2022-09-12 2022-09-12 S Sale

Ahrens Brenton Karl

Non-Executive Director
15,000 -15.4%
2.31
34,608 USD 		15,000 -15.4% 2.31 34,608 USD
2022-09-12 2022-09-09 S Sale

Ahrens Brenton Karl

Non-Executive Director
15,000 -13.4%
2.32
34,730 USD 		15,000 -13.4% 2.32 34,730 USD
2022-09-12 2022-09-08 S Sale

Ahrens Brenton Karl

Non-Executive Director
3,298 -2.9%
2.26
7,465 USD 		3,298 -2.9% 2.26 7,465 USD
2022-09-09 2022-09-07 B Purchase

Dunne Michael W.

Non-Executive Director
10,000 +39.1%
2.22
22,200 USD 		10,000 +39.1% 2.22 22,200 USD
2022-03-15 2022-03-14 S Sale

Matthews Judith M.

Chief Financial Officer

Officer
47,132 -36.6%
0.38
17,910 USD 		47,132 -36.6% 0.38 17,910 USD
2021-02-12 2021-02-12 S Sale

DENNER ALEXANDER J

Major owner
10,619,949 -100.0%
2.27
24,107,284 USD 		10,619,949 -100.0% 2.27 24,107,284 USD
2021-02-12 2021-02-11 S Sale

DENNER ALEXANDER J

Major owner
10,000,000 -48.5%
2.59
25,900,000 USD 		10,000,000 -48.5% 2.59 25,900,000 USD
2021-01-27 2021-01-26 S Sale

Fishman Corey N.

President & CEO

Executive Director
85,445 -21.0%
1.73
147,820 USD 		85,445 -21.0% 1.73 147,820 USD
2021-01-27 2021-01-26 S Sale

Dunne Michael W.

Non-Executive Director
33,143 -11.4%
1.73
57,337 USD 		33,143 -11.4% 1.73 57,337 USD
2021-01-27 2021-01-26 S Sale

Matthews Judith M.

Chief Financial Officer

Officer
33,868 -54.2%
1.73
58,592 USD 		33,868 -54.2% 1.73 58,592 USD
2020-10-28 2020-10-27 B Purchase

Dunne Michael W.

Chief Scientific Officer

Officer
61,540
0.00
0 USD 		61,540 0.00 0 USD
2020-10-02 2020-09-30 PS Planned sale

Matthews Judith M.

Chief Financial Officer

Officer
56,130 -100.0%
1.64
92,053 USD 		56,130 -100.0% 1.64 92,053 USD
2020-06-03 2020-06-02 S Sale

Sofinnova Venture Partners IX, L.P.

Major owner
400,000 -24.6%
1.61
642,960 USD 		400,000 -24.6% 1.61 642,960 USD
2020-06-03 2020-06-01 S Sale

Sofinnova Venture Partners IX, L.P.

Major owner
100,000 -5.8%
1.69
169,120 USD 		100,000 -5.8% 1.69 169,120 USD
2018-12-04 2018-11-30 B Purchase

Kelly David George

Non-Executive Director
10,000 +104.7%
6.29
62,887 USD 		10,000 +104.7% 6.29 62,887 USD
2018-11-01 2018-10-30 B Purchase

Chin Mark

Non-Executive Director
58,000 +5.6%
6.10
353,800 USD 		58,000 +5.6% 6.10 353,800 USD
2018-09-06 2018-09-04 B Purchase

Dunne Michael W.

Chief Scientific Officer

Officer
500 +0.3%
10.00
5,000 USD 		500 +0.3% 10.00 5,000 USD
2018-08-28 2018-08-27 B Purchase

Dunne Michael W.

Chief Scientific Officer

Officer
500 +0.3%
10.00
5,000 USD 		500 +0.3% 10.00 5,000 USD
2018-08-28 2018-08-24 B Purchase

Dunne Michael W.

Chief Scientific Officer

Officer
500 +0.3%
10.00
5,000 USD 		500 +0.3% 10.00 5,000 USD
2018-08-27 2018-08-23 B Purchase

Edick Paul R

Non-Executive Director
500 +2.0%
10.44
5,219 USD 		500 +2.0% 10.44 5,219 USD
2018-08-21 2018-08-17 B Purchase

Fishman Corey N.

President & CEO

Executive Director
2,000 +0.8%
8.73
17,466 USD 		2,000 +0.8% 8.73 17,466 USD
2018-06-01 2018-05-30 B Purchase

Chin Mark

Non-Executive Director
337,606 +48.6%
13.00
4,388,878 USD 		337,606 +48.6% 13.00 4,388,878 USD
2018-05-31 2018-05-30 B Purchase

Lathi Vijay K

Major owner
384,615 +inf%
13.00
4,999,995 USD 		384,615 +inf% 13.00 4,999,995 USD
2018-05-31 2018-05-30 B Purchase

Lathi Vijay K

Major owner
278,062 +35.0%
13.00
3,614,806 USD 		278,062 +35.0% 13.00 3,614,806 USD
2018-05-31 2018-05-30 B Purchase

HUNT RONALD

Non-Executive Director Major owner
384,615 +inf%
13.00
4,999,995 USD 		384,615 +inf% 13.00 4,999,995 USD
2018-05-31 2018-05-30 B Purchase

HUNT RONALD

Non-Executive Director Major owner
278,062 +35.0%
13.00
3,614,806 USD 		278,062 +35.0% 13.00 3,614,806 USD
2018-05-30 2018-05-30 B Purchase

Fishman Corey N.

President & CEO

Executive Director
3,000 +1.3%
13.00
39,000 USD 		3,000 +1.3% 13.00 39,000 USD
2018-05-30 2018-05-30 B Purchase

CANAAN X L.P.

Non-Executive Director Major owner
506,656 +41.3%
13.00
6,586,528 USD 		506,656 +41.3% 13.00 6,586,528 USD
2018-05-30 2018-05-30 B Purchase

Matthews Judith M.

Chief Financial Officer

Officer
4,000 +7.7%
13.00
52,000 USD 		4,000 +7.7% 13.00 52,000 USD
2018-05-30 2018-05-30 B Purchase

Ahrens Brenton Karl

Non-Executive Director
506,656 +41.3%
13.00
6,586,528 USD 		506,656 +41.3% 13.00 6,586,528 USD
2018-05-30 2018-05-30 B Purchase

Malik Shahzad

Non-Executive Director
228,840 +37.5%
13.00
2,974,920 USD 		228,840 +37.5% 13.00 2,974,920 USD
2018-05-30 2018-05-30 B Purchase

Malik Shahzad

Non-Executive Director
8,144 +37.5%
13.00
105,872 USD 		8,144 +37.5% 13.00 105,872 USD
2018-05-30 2018-05-30 B Purchase

Heron Patrick J

Non-Executive Director Major owner
101,150 +42.1%
13.00
1,314,950 USD 		101,150 +42.1% 13.00 1,314,950 USD
2018-05-30 2018-05-30 B Purchase

Heron Patrick J

Non-Executive Director Major owner
354,949 +42.1%
13.00
4,614,337 USD 		354,949 +42.1% 13.00 4,614,337 USD
2018-05-30 2018-05-30 B Purchase

Dunne Michael W.

Chief Scientific Officer

Officer
2,000 +1.4%
13.00
26,000 USD 		2,000 +1.4% 13.00 26,000 USD
2018-05-30 2018-05-30 B Purchase

HEALY JAMES

Non-Executive Director Major owner
500,000 +40.8%
13.00
6,500,000 USD 		500,000 +40.8% 13.00 6,500,000 USD
2018-05-30 2018-05-30 B Purchase

Sofinnova Venture Partners IX, L.P.

Major owner
500,000 +40.8%
13.00
6,500,000 USD 		500,000 +40.8% 13.00 6,500,000 USD